Ashu Tyagi serves as Executive at Y-mAbs Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ashu Tyagi has executed 6 insider transactions totaling $6.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 16, 2025 involved selling 25,080 shares valued at $0.
Ashu Tyagi currently holds 30,905 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashu Tyagi has been a net buyer of YMAB stock. They have purchased $6.9M and sold $0 worth of shares.
Ashu Tyagi's most recent insider trade was on Sep 16, 2025, when they sold 25,080 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.60 |
| Discretionary |
| Jun 30, 2025 | YMAB | $0 | Award | 25,080 | $N/A | Discretionary |
| Jun 11, 2024 | YMAB | $0 | Award | 3,495 | $N/A | Discretionary |
| Jun 8, 2023 | YMAB | $0 | Award | 2,330 | $N/A | Discretionary |
| Sep 25, 2018 | YMAB | $6.9M | Purchase | 430,174 | $16.00 | Discretionary |